The Case for Restructuring the Medicare Prescription Drug Benefit.
作者信息
Frakt Austin, Miller Mark
机构信息
Partnered Evidence-Based Policy Resource Center, VA Boston Healthcare System, Boston, MA.
School of Public Health, Boston University, Boston, MA.
出版信息
Health Serv Res. 2018 Dec;53(6):4132-4137. doi: 10.1111/1475-6773.13019. Epub 2018 Aug 1.
Abstract
摘要
相似文献
1
The Case for Restructuring the Medicare Prescription Drug Benefit.重组医疗保险处方药福利的理由。
Health Serv Res. 2018 Dec;53(6):4132-4137. doi: 10.1111/1475-6773.13019. Epub 2018 Aug 1.
2
Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.药品与医疗器械：医疗保险D部分。年终问题简报。
Issue Brief Health Policy Track Serv. 2008 Jan 7:1-23.
3
Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.药品和医疗器械：医疗保险D部分。年终问题简报。
Issue Brief Health Policy Track Serv. 2009 Jan 5:1-26.
4
Pharmaceuticals and medical devices: Medicare Part D. Issue brief.药品和医疗器械：医疗保险D部分。问题简报。
Issue Brief Health Policy Track Serv. 2012 Dec 31:1-32.
5
Medicare program; Medicare prescription drug benefit. Final rule.医疗保险计划；医疗保险处方药福利。最终规则。
Fed Regist. 2005 Jan 28;70(18):4193-585.
6
Pharmaceuticals and medical devices: Medicare Part D.药品和医疗器械：医疗保险D部分。
Issue Brief Health Policy Track Serv. 2012 Jan 3:1-37.
7
Medicare program; establishment of the Medicare advantage program. Final rule.医疗保险计划；医疗保险优势计划的设立。最终规则。
Fed Regist. 2005 Jan 28;70(18):4587-741.
8
Overview of Medicare Part D prescription drug benefit: potential implications for patients with psychotic disorders.医疗保险D部分处方药福利概述：对精神病患者的潜在影响
Am J Health Syst Pharm. 2007 Jan 15;64(2 Suppl 1):S18-23; quiz S24-5. doi: 10.2146/ajhp060592.
9
Pharmaceuticals and medical devices: Medicare Part D.药品和医疗器械：医疗保险D部分。
Issue Brief Health Policy Track Serv. 2013 Dec 30:1-32.
10
Medicare program; changes to the requirements for Part D prescribers. Interim final rule with comment period.医疗保险计划；D部分开处方者要求的变更。有意见征求期的暂行最终规则。
Fed Regist. 2015 May 6;80(87):25958-66.
引用本文的文献
1
Medicare Part D: Time for Re-Modernization?医疗保险处方药部分：是时候重新现代化了？
Health Serv Res. 2019 Dec;54(6):1174-1183. doi: 10.1111/1475-6773.13221. Epub 2019 Oct 30.
2
Analysis of Proposed Medicare Part B to Part D Shift With Associated Changes in Total Spending and Patient Cost-Sharing for Prescription Drugs.分析拟议的医疗保险 B 部分到 D 部分的转变以及处方药总支出和患者自付费用的相关变化。
JAMA Intern Med. 2019 Mar 1;179(3):374-380. doi: 10.1001/jamainternmed.2018.6417.
本文引用的文献
1
Growing Reinsurance Payments Weaken Competitive Bidding in Medicare Part D.再保险赔付不断增加削弱了医疗保险D部分的竞争性投标。
Health Serv Res. 2018 Dec;53(6):4371-4380. doi: 10.1111/1475-6773.12866. Epub 2018 May 7.
Zotero 插件